Company: RNAC
Filing Date: 2025-01-08
Form Type: 424B7
Source: 0001140361-25-000634
Chunk: 25

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-01-08
Form: 424B7
Chunk 25
---
 knowledge, unless otherwise indicated, all persons named in the table above have sole voting and investment power with respect to their shares of Common Stock. Unless otherwise indicated, the address of each beneficial owner listed below is 7495 New Horizon Way, Frederick, Maryland 21703. |

| (2) | “Beneficial ownership” is a term broadly defined by the SEC in Rule 13d-3 under the Exchange Act, and includes more than the typical form of stock ownership, that is, stock held in the person’s name. The term also includes what is referred to as “indirect ownership,” meaning ownership of shares as to which a person has or shares investment power. Notwithstanding the foregoing, the beneficial ownership amounts assume the sale of all Common Stock that may be offered pursuant to this prospectus without taking into account certain limitations, including the Series A Beneficial Ownership Limitation, of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. |

| (3) | Based on information known to us, and consists of (i) 8,449,773 shares of Common Stock held directly by Timothy A. Springer, Ph.D., a member of our Board of Directors, (ii) 113,587 shares of Common Stock issuable upon exercise of underlying warrants exercisable within 60 days of November 22, 2024 held directly by Timothy A. Springer, Ph.D., (iii) 2,533 shares of Common Stock issuable upon exercise of outstanding options within 60 days of November 22, 2024 and held directly by Timothy A. Springer, Ph.D., (iv) 1,977 shares of Common Stock underlying restricted stock units vesting within 60 days of November 22, 2024, (v) 529,798 shares of Common Stock held by TAS Partners LLC, or TAS, an affiliate of Dr. Springer, directly, (vi) 33,408 shares of Common Stock issuable upon exercise of underlying warrants exercisable within 60 days of November 22, 2024 held by TAS directly, (vii) 330,695 shares of Common Stock held by Dr. Chafen Lu, Dr. Springer’s wife, and (viii) 20,045 shares of Common Stock issuable upon exercise of underlying warrants exercisable within 60 days of November 22, 2024 held by Dr. Chafen Lu. Dr. Springer is the sole managing member of TAS. Dr. Springer exercises sole